NutraGenesis LLC is pleased to report Sensoril® sales for the first quarter of 2014 are up significantly over the same period in 2013. This continues the trend of increasing sales which has occurred over the last five years. The tremendous sales growth is attributed to both new customer acquisitions as well as growth of our long-term customers’ business with Sensoril. NutraGenesis is the exclusive North American sales and marketing representative for Sensoril under license from Natreon Inc. of New Brunswick, N.J.
“We are delighted to see the results of the first quarter and what it means for Sensoril sales for the balance of the year,” said Vice President of Sales Tiea Zehnbauer, MS. “Sensoril has been growing at double digits for the past several years. We believe that this growth is a reflection of the success our customers are experiencing selling products that contain Sensoril. The long-term growth is representative of just how much consumer acceptance and satisfaction there is for Sensoril in the marketplace. Simply put, people want results that they can really feel and Sensoril delivers.”
Sensoril possesses multiple health benefits, superior efficacy demonstrated in eight randomized, double-blind, placebo-controlled human clinical trials, broad IP status including multiple patents, and a comprehensive safety record. That’s why Sensoril is the best-selling, branded ashwagandha extract of choice in the North American market. Sensoril is now used in over 200 SKUs to help support stress, mental cognition, sleep, metabolic wellness, adrenal function, thyroid function, sports performance and more.
Sensoril was developed by Fulbright scholar and renowned ashwagandha researcher Dr. Shibnath Ghosal to create a next-generation ashwagandha extract that exceeds conventional root only extracts in efficacy and bioactive content. Sensoril represents the culmination of the best that Ayurvedic tradition has to offer combined with the most advanced scientific innovations in nutritional technology to produce the safest, most efficacious ashwagandha extract available. Standardized to a minimum of 10% glycowithanolides, Sensoril possesses the highest level of adaptogenic bioactives of any ashwagandha extract sold. Its superior efficacy stems from a patented, extraction process that concentrates health-promoting glycowithanolide bioactives found in both roots and leaves. The extraction of roots and leaves is unique to Sensoril and cannot be copied by other manufacturers because the process is patented. This process also ensures that minimal levels of Withaferin A remain in the finished extract. Sensoril is standardized to contain no more than 0.5% Withaferin A. Withaferin A, an aglycone found in both roots and leaves, does not provide any adaptogenic health benefits.
Sensoril is rich in a full suite of bioactives and other nutrients which are captured during the extraction process, making it a truly full-spectrum ingredient. Sensoril has been shown to be well tolerated in human clinical research, is GRAS affirmed and is non-GMO. Sensoril has received an Investigation New Drug (IND) number in association with its use in a human clinical trial at the University of Pittsburgh. This indicates that Sensoril’s rigorous safety and toxicity testing has satisfied FDA-approved safety guidelines.